- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03054415
Anorectal Function and Neuronal-glial-epithelial Unit in Healthy Subjects (ANOSAIN)
This study aims to assess the phenotype of the enteric nervous system (enteric neurons) in healthy subjects.
The enteric nervous system (ENS) is composed by enteric neurons and enteric glial cells. There is a cross-talk between ENS and the intestinal epithelial barrier (IEB). ENS and IEB together constitute the neuronal-glial-epithelial unit. This unit has a key role in gut functions. The characteristics and the phenotype of the ENS also change according to age and environmental factors. Similar study is ongoing for patients with Spina Bifida. Anorectal data and phenotype of the neuronal-glial-epithelial unit in healthy subjects is required to assess abnormality of these items in patients with neurological disease including Spina Bifida.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Rennes, France, 35033
- Rennes University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- subject aged between 18 and 65 years old age and sex matched with the first sixteen patients included and evaluated in the ANOSPIN study
- subject who gave their written consent to participate to the present study
- subject not included in another study
- subject covered by social insurance system
Exclusion Criteria:
- Pregnant or nursing women;
- Anticoagulants therapy or coagulation disorders;
- Past history of anal or rectal surgery
- Crohn disease or ulcerative colitis
- Irritable bowel syndrome according to the Rome III criteria;
- Past history of pelvic radiotherapy
- Pas history of rectal or anal cancer
- Anorectal symptoms : faecal incontinence, constipation, anorectal pain, rectal prolapse;
- CCIS >5 (faecal incontinence);
- Kess Score >9 (constipation);
- Colonic irrigation;
- Use of laxatives;
- Abnormal colonic mucosa
- Period of exclusion;
- Patient under guardianship or unable to give their consent;
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Healthy Subjects
|
colonic biopsies during endoscopy and anal manometry with barostat and anal endoflip
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of enteric neurons per ganglion
Time Frame: data collected at the day of endoscopy
|
colonic biopsies will be used to study intestinal permeability, colonic inflammation and enteric nervous system
|
data collected at the day of endoscopy
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
density and activity of the enteric glial cells
Time Frame: data collected at the day of endoscopy
|
colonic biopsies will be used to study intestinal permeability, colonic inflammation and enteric nervous system
|
data collected at the day of endoscopy
|
|
rectal adaptation
Time Frame: data collected at the day of endoscopy
|
rectal adaptation is defined by a volume variation during ascending pressure (phasic distension).
It will be performed with a bag connected to electronic barostat
|
data collected at the day of endoscopy
|
|
rectal perception
Time Frame: data collected at the day of endoscopy
|
It will performed by using 6-point Likert scale ranging from 0 (no sensation) to 6 (intolerable pain)
|
data collected at the day of endoscopy
|
|
anal distensiblity
Time Frame: data collected at the day of endoscopy
|
It will be performed by using ENDOFLIP
|
data collected at the day of endoscopy
|
|
intestinal permeability
Time Frame: data collected at the day of endoscopy
|
Biopsy samples collected at the time of colonoscopy will be use within a Ussing Chamber able to assess intestinal permeability.
The Ussing chamber is used to measure the short-circuit current as an indicator of net ion transport taking place across an epithelium, such as gut mucosa.
The measure will be performed on 2 biopsies from each patient.
|
data collected at the day of endoscopy
|
|
macroscopic and microscopic colonic inflammation
Time Frame: data collected at the day of endoscopy
|
Colonic inflammation will be assessed during the scope procedure.
The physician will assess the normality of the mucosa or not in case of mucosal erythema, ulceration or a decrease of the vascular pattern.
Microscopic inflammation will be assessed by the pathologist according to neutrophils infiltration in the gut, crypt abscess, crypt distortion.
|
data collected at the day of endoscopy
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Charlène Brochard, Md, Rennes University Hospital
Publications and helpful links
General Publications
- Lefevre C, Le Roy C, Bessard A, Le Berre-Scoul C, Marchix J, Coron E, Le Rhun M, Brochard C, Perrouin-Verbe B, Neunlist M. Region-specific remodeling of the enteric nervous system and enteroendocrine cells in the colon of spinal cord injury patients. Sci Rep. 2023 Oct 6;13(1):16902. doi: 10.1038/s41598-023-44057-y.
- Brochard C, Bouguen G, Olivier R, Durand T, Henno S, Peyronnet B, Pagenault M, Lefevre C, Boudry G, Croyal M, Fautrel A, Esvan M, Ropert A, Dariel A, Siproudhis L, Neunlist M. Altered epithelial barrier functions in the colon of patients with spina bifida. Sci Rep. 2022 May 3;12(1):7196. doi: 10.1038/s41598-022-11289-3.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016-A01541-50
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.